ROBERT HIGHTOWER: Open Payments
NPI 1861425878 · CUSHING, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,297 in 76 payments from 24 companies in 2025. Trend: 2023 $1,468 · 2024 $1,443 · 2025 $1,297
Food & beverage: $1,297
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $173 |
| ABBVIE INC. | 18 | $159 |
| GlaxoSmithKline, LLC. | 8 | $134 |
| PFIZER INC. | 6 | $100 |
| Viatris Specialty LLC | 5 | $96 |
| Axsome Therapeutics, Inc. | 4 | $85 |
| Insulet Corporation | 1 | $76 |
| Lundbeck LLC | 3 | $64 |
| Lilly USA, LLC | 3 | $50 |
| Novo Nordisk Inc | 3 | $49 |
Products named: BREZTRI, TRELEGY ELLIPTA, YUPELRI, REXULTI, Omnipod, VRAYLAR, Auvelity, PREVNAR 20.
Industry payments across OK — which companies pay providers there.
